Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP555287.RArY_Z8CAZrK4c6tKK_M4oe1dFH62plMK0uo8nlXbC3Sc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP555287.RArY_Z8CAZrK4c6tKK_M4oe1dFH62plMK0uo8nlXbC3Sc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP555287.RArY_Z8CAZrK4c6tKK_M4oe1dFH62plMK0uo8nlXbC3Sc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP555287.RArY_Z8CAZrK4c6tKK_M4oe1dFH62plMK0uo8nlXbC3Sc130_provenance.
- NP555287.RArY_Z8CAZrK4c6tKK_M4oe1dFH62plMK0uo8nlXbC3Sc130_assertion description "[From a translational standpoint, hypermethylation can be used as a marker of recurrent disease or progression, for example, in MDS, or response to chemotherapy, such as MGMT methylation in B-cell non-Hodgkin's lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP555287.RArY_Z8CAZrK4c6tKK_M4oe1dFH62plMK0uo8nlXbC3Sc130_provenance.
- NP555287.RArY_Z8CAZrK4c6tKK_M4oe1dFH62plMK0uo8nlXbC3Sc130_assertion evidence source_evidence_literature NP555287.RArY_Z8CAZrK4c6tKK_M4oe1dFH62plMK0uo8nlXbC3Sc130_provenance.
- NP555287.RArY_Z8CAZrK4c6tKK_M4oe1dFH62plMK0uo8nlXbC3Sc130_assertion SIO_000772 14585279 NP555287.RArY_Z8CAZrK4c6tKK_M4oe1dFH62plMK0uo8nlXbC3Sc130_provenance.
- NP555287.RArY_Z8CAZrK4c6tKK_M4oe1dFH62plMK0uo8nlXbC3Sc130_assertion wasDerivedFrom befree-20150227 NP555287.RArY_Z8CAZrK4c6tKK_M4oe1dFH62plMK0uo8nlXbC3Sc130_provenance.
- NP555287.RArY_Z8CAZrK4c6tKK_M4oe1dFH62plMK0uo8nlXbC3Sc130_assertion wasGeneratedBy ECO_0000203 NP555287.RArY_Z8CAZrK4c6tKK_M4oe1dFH62plMK0uo8nlXbC3Sc130_provenance.
- befree-20150227 importedOn "2015-02-27" NP555287.RArY_Z8CAZrK4c6tKK_M4oe1dFH62plMK0uo8nlXbC3Sc130_provenance.